Implantable bioartificial kidney is a medical
device that provides the many health benefits of a kidney transplants and
addresses the issue of limited donors. The bioartificial kidney consists of two
parts. The hemofilter is made from silicon semiconductor membranes. It filters
waste products from the blood and protects the patient's blood from infection.
The bioreactor consists of engineered human renal tubule cells. This technology
replicates the functions of the kidney and balances the electrolytes in the
blood. The device is powered by the patient's own blood pressure, which
eliminates the need for external tubes or immunosuppressants.
A research team led by Dr. Shuvo Roy of the
University of California San Francisco is developing an implantable
bioartificial kidney. It would be the size of a coffee cup, and it would treat
end-stage renal disease, which affects more than 600,000 people in the U.S.
today. The technology could help patients live more active, healthy lives, and
lead normal, healthy lives. The technology has also been praised by the FDA.
Market definition of the global implantable
bioartificial kidney market along with the analysis of different
influencing factors like drivers, restraints, and opportunities.
The bioartificial kidney is a multifaceted
device combining a bioreactor and cultured kidney cells. The transplanted
kidney performs the major functions of a real kidney, but without the need for
blood thinners or immune suppressing drugs. The implanted cells will take care
of electrolytes and other nutrients naturally. The FDA has also selected the
implantable bioartificial organ to participate in the IP 2.0 pilot program. The
implantable Bioartificial Kidney is the first step in a future bioartificial
kidney. Its primary goal is to help patients with diabetes by removing sugar
and protein from their bodies. This device will also help those with severe hypoglycemic
disorders. Its development will require the collaboration of several teams from
different scientific fields. It could be the first step in creating a
functional bioartificial kidney. In September 2021, The Kidney Project of
University of California San Francisco successfully implanted a prototype of
its bioartificial kidney in a preclinical trial.
Anthony Constantinou | Anthony Constantinou CEO CWM FX says There are many kidney donor programs going around the world over. However, it is a big decision for any individual to decide for their kidney donation. For any kidney donor, before making any decision, it is important that you will consult with good health care professionals.
ReplyDelete